A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 9/14 (2006.01) A61K 9/28 (2006.01)
Patent
CA 2251886
The invention is directed to well-tolerated pharma-ceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid re-lease of the active substance takes place.
L'invention concerne des compositions pharmaceutiques pour administration par voie orale, bien tolérées et contenant de l'ibandronate ou un sel physiologiquement tolérable d'ibandronate en tant que principe actif. La forme d'administration est constituée d'une partie interne renfermant le principe actif, enrobée d'une partie sans principe actif permettant une libération rapide du principe actif.
Gabel Rolf-Dieter
Mockel Jorn
Woog Heinrich
Boehringer Mannheim Gmbh
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Roche Diagnostics Gmbh
LandOfFree
An oral pharmaceutical formulation containing ibandronate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with An oral pharmaceutical formulation containing ibandronate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An oral pharmaceutical formulation containing ibandronate will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1475687